Table 4 Proportion of patients alive at 6 and 12 months after receiving either I or O alone or both agents as sequenced treatments

From: Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis

 

I only

O only

I then O

O then I

Proportion alive at 6 months

0.46

0.55

0.89

0.91

Proportion alive at 12 months

0.25

0.30

0.58

0.61

  1. I, irinotecan; O, oxaliplatin.
Back to article page